Wegovy vs Mounjaro: Understanding the Differences Between These Weight Management Medicines
Medical Disclaimer: This article is for general informational purposes only and does not constitute medical advice, diagnosis or treatment. Wegovy, Mounjaro and other prescription medicines have specific indications, contraindications, warnings, strengths and formulations that may vary by product and country. Always consult your doctor, pharmacist or another qualified healthcare professional before starting, stopping or changing any medication.
Prescription medicines have become an option for some people managing obesity or excess weight alongside weight-related health concerns. Two medicines that are frequently discussed are Wegovy (semaglutide) and Mounjaro (tirzepatide).
Although both are administered once weekly and can affect appetite and body weight, they contain different active ingredients and work through different hormonal pathways. Their approved uses, available strengths and prescribing requirements can also vary between countries.
This guide explains the key differences between Wegovy and Mounjaro and what patients should know before discussing either treatment with a healthcare professional.
Wegovy and Mounjaro at a Glance
Wegovy | Mounjaro | |
Active ingredient | Semaglutide | Tirzepatide |
Medicine class | GLP-1 receptor agonist | GIP and GLP-1 receptor agonist |
Administration | Once-weekly injection | Once-weekly injection |
Main role | Weight management in approved populations | Type 2 diabetes treatment; weight-management indications depend on country and product |
Prescription | Yes | Yes |
Dose | Increased gradually according to the prescribing information | Increased gradually according to the prescribing information |
The exact indication, strength and formulation available should always be checked against the product information applicable to the patient's country.
What Is Wegovy?
Wegovy contains semaglutide, a GLP-1 receptor agonist.
It is prescribed in certain markets for chronic weight management in eligible patients, alongside a reduced-calorie diet and increased physical activity. Its approved use depends on the applicable regulatory authority and product information.
Semaglutide acts on GLP-1 receptors involved in appetite regulation and glucose metabolism. It can reduce appetite and increase feelings of fullness, which can help some patients reduce their food intake.
Wegovy is administered once weekly, with the dose generally increased gradually according to the prescribing information to help patients adjust to treatment.
The available strengths and formulations can differ between markets, so patients should not assume that a strength listed online is available or appropriate in every country.
FDA Wegovy Prescribing Information
What Is Mounjaro?
Mounjaro contains tirzepatide.
In the United States, Mounjaro is indicated for the treatment of type 2 diabetes, while Zepbound contains the same active ingredient, tirzepatide, and is approved for certain weight-management indications. Brand names and approved uses can differ between countries, so patients should check the product information applicable to their location.
Tirzepatide is different from semaglutide because it acts on two hormonal pathways: GIP and GLP-1 receptors.
Mounjaro is administered once weekly and treatment generally starts at a lower dose before being increased according to the prescribing information and the patient's individual treatment plan.
One important point when comparing these medicines is that Mounjaro's approved indications are not identical in every country. For example, regulatory approvals and product labelling differ between markets.
Patients should therefore rely on the product information applicable to their location rather than assuming that information about Mounjaro from another country applies to them.
How Are Wegovy and Mounjaro Different?
The simplest difference is their active ingredients and mechanisms.
Wegovy contains semaglutide and acts on the GLP-1 receptor.
Mounjaro contains tirzepatide and acts on both GIP and GLP-1 receptors.
Both can influence appetite and food intake, but they are not the same medicine and should not be considered interchangeable.
The choice between them depends on the individual's medical history, treatment goals, other medicines, eligibility and the approvals applicable in their country.
Which Is More Effective for Weight Loss?
This is one of the most common questions about Wegovy and Mounjaro, but there is no appropriate answer based simply on the brand name.
Clinical trials have reported substantial weight reduction with both medicines. A 2025 head-to-head trial published in the New England Journal of Medicine compared tirzepatide with semaglutide in adults with obesity who did not have type 2 diabetes. At 72 weeks, average weight reduction was greater with tirzepatide than with semaglutide in that study. However, these results represent average outcomes in a specific study population and do not mean that tirzepatide will produce greater weight loss for every individual.
The appropriate treatment should therefore be selected with a healthcare professional rather than based solely on comparative weight-loss figures.
How Do These Medicines Affect Appetite?
Both medicines act on hormone pathways involved in appetite regulation.
They may:
Reduce appetite
Increase feelings of fullness
Affect food intake
Slow gastric emptying, particularly during treatment
The response varies between individuals, and a healthcare professional can assess whether treatment is appropriate and whether adjustments are needed.
What About the Doses?
Dose information needs particular care when comparing Wegovy and Mounjaro.
The medicines use different active ingredients and different dosing schedules, so their milligram strengths cannot be directly compared.
For example, a dose of semaglutide should not be compared numerically with a dose of tirzepatide to determine which is “stronger.”
Both treatments generally use gradual dose escalation, but the specific schedule should come from the applicable prescribing information and the patient's healthcare professional.
This is also why patients should never change between the medicines by attempting to calculate an equivalent dose themselves.
Who May Be Considered for Treatment?
Eligibility depends on the medicine, country, regulatory approval and the patient's individual circumstances.
Healthcare professionals may consider prescription weight-management treatment for people who meet specified criteria relating to body weight or obesity and, in some cases, weight-related health conditions.
The decision is not based on weight alone.
A clinician may also consider:
Existing medical conditions
Current medicines
Pregnancy or plans for pregnancy
Previous weight-management attempts
Gastrointestinal health
Blood glucose status
Cardiovascular and other health factors
Potential risks and benefits of treatment
Treatment criteria can differ between countries, so patients should follow the guidance applicable to their location. WHO — Obesity and Overweight
What Side Effects Can Occur?
Wegovy and Mounjaro can cause gastrointestinal side effects.
Commonly reported effects include:
Nausea
Diarrhoea
Vomiting
Constipation
Abdominal discomfort
These effects can be more noticeable when treatment is started or when the dose is increased.
Not everyone experiences the same side effects, and some may require medical attention.
Patients should read the product information supplied with their medicine and speak with their doctor or pharmacist if they develop concerning, severe or persistent symptoms.
Important Safety Considerations
Before starting Wegovy or Mounjaro, tell your healthcare professional about your medical history and all medicines you take.
Particular attention may be needed if you:
Are pregnant, planning pregnancy or breastfeeding
Have a history of pancreatitis
Have significant gastrointestinal problems
Have kidney problems
Have gallbladder problems
Use other medicines that affect blood glucose
Are taking another GLP-1-based medicine or tirzepatide
The exact warnings and contraindications differ between products and countries, so the relevant prescribing information should always be consulted.
For example, the U.S. prescribing information for Wegovy includes a boxed warning concerning thyroid C-cell tumours and contraindicates its use in people with a personal or family history of medullary thyroid carcinoma or in people with MEN 2. Product warnings and contraindications may differ in other countries, so the applicable prescribing information should always be checked.
Wegovy vs Mounjaro: Can You Take Them Together?
Wegovy and tirzepatide products should not be combined or switched without medical supervision. They contain different active ingredients and use different dosing schedules, so patients should not attempt to calculate an equivalent dose or make a direct substitution themselves.
They affect overlapping hormonal pathways, and using prescription weight-management medicines together without appropriate medical direction could increase the risk of adverse effects.
If your current medicine is not producing the expected results, speak with your doctor rather than changing the dose or adding another medicine yourself.
Why Brand Name, Strength and Formulation Matter
When purchasing prescription medicines online, checking the active ingredient is just as important as checking the brand name.
For example:
Wegovy → semaglutide
Mounjaro → tirzepatide
However, the active ingredient alone is still not enough.
Before ordering, check:
Product/brand name
Active ingredient
Strength
Dosage form
Quantity
Packaging
Batch or lot information
Expiry date
This is particularly important when purchasing medicines internationally. The same active ingredient may be marketed under different brand names, while strengths, packaging and approved indications can vary between countries.
A practical example
A patient may know a medicine by its brand name but encounter different packaging or strengths when purchasing from another market. For example, tirzepatide is marketed under different brand names depending on its approved indication and country. Before ordering, compare the brand name, active ingredient, strength, dosage form and intended use with the prescription or product information. If any detail does not match, confirm it with a pharmacist before using the medicine.
Can Wegovy or Mounjaro Be Ordered Online?
Prescription medicines may be available through online pharmacies where permitted by applicable regulations.
However, patients should not purchase these medicines from websites that offer them without appropriate prescription requirements or medical oversight.
Before ordering, check that:
The pharmacy is appropriately licensed or authorised
Prescription requirements are clearly explained
Product information is provided
The medicine matches the prescription
The strength and formulation are correct
Delivery requirements are clear
Any applicable destination-country requirements are understood
For international orders, regulations relating to prescription medicines and importation can differ by destination.
Be Careful With Unverified GLP-1 Products
The popularity of medicines such as semaglutide and tirzepatide has also created opportunities for counterfeit or unauthorised products.
A medicine being sold online at an unusually low price does not necessarily mean it is a good deal.
Be cautious when a website:
Offers prescription medicines without appropriate documentation
Does not identify the pharmacy clearly
Makes unrealistic claims
Provides little or no product information
Uses unclear contact details
Cannot explain where medicines are sourced
If packaging, labelling or the medicine itself appears unusual, speak with the supplying pharmacy or a healthcare professional before using it.
What About Lifestyle Changes?
Prescription weight-management medicines are generally used as part of a broader approach to managing weight.
Depending on individual needs, this may include:
Balanced nutrition
Regular physical activity
Adequate sleep
Behavioural support
Monitoring by a healthcare professional
Medication does not replace healthy lifestyle habits or ongoing medical care.
About Gaia Pharmacy
Gaia Pharmacy provides an online platform through which customers can explore and order medicines, subject to applicable prescription and regulatory requirements.
For prescription medicines such as weight-management treatments, customers should ensure they have the appropriate prescription and carefully check the product details before ordering.
Availability and delivery requirements may vary depending on the destination.
Frequently Asked Questions
Is Wegovy the same as Mounjaro?
No. Wegovy contains semaglutide, while Mounjaro contains tirzepatide. They act on different but related hormonal pathways.
Which is better for weight loss, Wegovy or Mounjaro?
Neither is universally “better.” Clinical studies have reported different average outcomes, but individual response varies. A healthcare professional should determine which option is appropriate based on your health and treatment goals.
Is Mounjaro a weight-loss medicine?
Its approved indications vary by country. In some markets, tirzepatide is approved specifically for chronic weight management under a different brand name. Patients should check the product and regulatory information applicable to their country rather than assuming that Mounjaro has the same indication everywhere.
What is the difference between semaglutide and tirzepatide?
Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on both GIP and GLP-1 receptors.
Can I switch from Wegovy to Mounjaro?
A healthcare professional may decide to switch a patient between treatments when clinically appropriate. Do not make the switch or calculate a new dose yourself.
Can I buy Wegovy or Mounjaro online?
They may be available through appropriately licensed or authorised online pharmacies where permitted. Prescription requirements and delivery rules vary by location.
How long do people take these medicines?
Treatment duration varies. Weight-management treatment may require ongoing assessment, and your healthcare professional can determine whether continuing, adjusting or changing treatment is appropriate.
Final Thoughts
Wegovy and Mounjaro are two different prescription medicines that have become important options in modern weight management.
Wegovy contains semaglutide and works through the GLP-1 pathway, while Mounjaro contains tirzepatide and acts on both GIP and GLP-1 pathways.
Clinical evidence suggests both can support significant weight reduction in appropriate patients, but individual responses vary. The medicines also differ in their approved indications, formulations and prescribing information across markets.
If you are considering either medicine, speak with a qualified healthcare professional before starting treatment. If ordering online, use an appropriately authorised pharmacy and carefully check the active ingredient, strength, formulation and product information before using any prescription medicine.
